Insider Trading Summary for Apellis Pharmaceuticals, Inc. (APLS): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Jan-24 4:10 PM View:	01-Jan-24 Grant 0	Chan Gerald Director		Apellis Pharmaceuticals, Inc. - APLS	41% 8.1K to 11.44K	0	0	--	--	Show Txns Hide Txns

15-Apr-24 4:09 PM View:	12-Apr-24 Option Exercise $19.78K	Dunlop A. Sinclair Director		Apellis Pharmaceuticals, Inc. - APLS	(16%) 403.83K to 339.37K	0	0	--	--	Show Txns Hide Txns

02-Jan-24 4:08 PM View:	01-Jan-24 Grant 0	MacHiels Alec Director		Apellis Pharmaceuticals, Inc. - APLS	15% 679.59K to 782.71K	0	0	--	--	Show Txns Hide Txns

02-Jan-24 4:12 PM View:	01-Jan-24 Grant 0	O'Brien Stephanie Monaghan Director		Apellis Pharmaceuticals, Inc. - APLS	41% 8.1K to 11.44K	0	0	--	--	Show Txns Hide Txns

08-Mar-24 7:45 AM View:	06-Mar-24 Option Exercise $52.10K	Watson David O. General Counsel		Apellis Pharmaceuticals, Inc. - APLS	7% 184.97K to 197.86K	0	0	--	--	Show Txns Hide Txns

Today 7:27 PM View:	Yesterday Gift 0	Sullivan Timothy Eugene Chief Financial Officer		Apellis Pharmaceuticals, Inc. - APLS	12% 133.94K to 149.57K	0	0	--	--	Show Txns Hide Txns

02-Jan-24 4:13 PM View:	01-Jan-24 Grant 0	Fonteyne Paul R. Director		Apellis Pharmaceuticals, Inc. - APLS	26% 13.1K to 16.44K	0	0	--	--	Show Txns Hide Txns

31-Jan-24 4:28 PM View:	30-Jan-24 Sale (Planned) ($57.86K)	Lewis Karen Chief People Officer		Apellis Pharmaceuticals, Inc. - APLS	12% 41.5K to 46.39K	0	0	--	--	Show Txns Hide Txns

14-Mar-24 4:17 PM View:	13-Mar-24 Private Sale ($645.84K)	Nicholson Nur Chief Technical Officer		Apellis Pharmaceuticals, Inc. - APLS	(12%) 63.91K to 56.29K	0	0	--	--	Show Txns Hide Txns

09-Apr-24 4:25 PM View:	08-Apr-24 Planned Option Sale ($3.74M)	Deschatelets Pascal Chief Scientific Officer		Apellis Pharmaceuticals, Inc. - APLS	9% 1.03M to 1.12M	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:05 PM View:	12-Feb-24 Private Sale ($77.80K)	Townsend Adam J. Chief Commercial Officer		Apellis Pharmaceuticals, Inc. - APLS	22% 76.0K to 92.45K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 4:19 PM View:	15-Mar-24 Private Sale ($10.39K)	Chopas James George VP/Chief Accounting Officer		Apellis Pharmaceuticals, Inc. - APLS	26% 30.86K to 38.88K	0	($28.79K) (2%)	--	$41.23 - $46.04	Show Txns Hide Txns

17-Jan-24 4:33 PM View:	16-Jan-24 Grant 0	Baumal Caroline Chief Medical Officer		Apellis Pharmaceuticals, Inc. - APLS	64% 35.68K to 58.38K	0	0	--	--	Show Txns Hide Txns

19-Mar-24 4:03 PM View:	18-Mar-24 Private Sale ($564.05K)	Delong Mark Jeffrey Chief Business & Strat Officer		Apellis Pharmaceuticals, Inc. - APLS	6% 51.75K to 54.69K	0	($6.03K)	--	$46.04	Show Txns Hide Txns

31-Jan-24 4:23 PM View:	30-Jan-24 Sale (Planned) ($63.63K)	Eisele Jeffrey Chief Development Officer		Apellis Pharmaceuticals, Inc. - APLS	6% 53.88K to 57.21K	0	0	--	--	Show Txns Hide Txns

05-Dec-23 7:40 PM View:	01-Dec-23 Planned Option Sale ($600.00K)	Scheibler Lukas Chief Research Officer		Apellis Pharmaceuticals, Inc. - APLS	(3%) 70.06K to 68.3K	0	($75.53K) (3%)	--	$43.01	Show Txns Hide Txns

05-Mar-24 4:07 PM View:	01-Mar-24 Option Sale ($16.03M)	Francois Cedric Chief Executive Officer Director		Apellis Pharmaceuticals, Inc. - APLS	11% 1.83M to 2.04M	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	($110.35K)	$41.23 - $46.04

Apellis Pharmaceuticals, Inc. (APLS)

Last Year

20-Apr-23 -- 19-Apr-24

Company Sentiment

Other

Other

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades